COMMUNIQUÉS West-GlobeNewswire

Achaogen Announces New Employment Inducement Grants
24/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 24, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]
The American Health Council Physician Board Appoints Laura Rainer, MD
24/11/2017
NEW YORK, Nov. 24, 2017 (GLOBE NEWSWIRE) -- Dr. Laura Rainer, Physician at Gulf Coast Medical Group, has been selected to join the Physician Board at the American Health Council. She will be sharing her knowledge and [...]
Galapagos increases share capital through warrant exercises
23/11/2017
Mechelen, Belgium; 23 November 2017, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 41,000 new ordinary [...]
Canada House’s Knalysis Technologies’ Self-Registration Drives Efficiency for US Customers
23/11/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 23, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]
Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose Monitoring
23/11/2017
SANTA CLARA, Calif., Nov. 23, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company [...]
Guerbet reinforces its expertise with the launch of Contrast&Care®, a contrast media injection management solution for radiology centers
23/11/2017
Contrast&Care ® has just obtained CE mark Contrast&Care will be presented at the RSNA Villepinte (France), November 23, 2017 (8:00 CET) - Guerbet (FR0000032526 GBT), the global specialist in contrast products [...]
Guerbet renforce son expertise avec le lancement de Contrast&Care®, une solution de gestion de l'injection des produits de contraste pour les centres d'imagerie médicale
23/11/2017
Contrast&Care ® vient d'obtenir le marquage CE Contrast&Care sera présenté au RSNA Villepinte (France), le 23 novembre 2017 (8 heures CET) - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de [...]
Saniona AB: Saniona AB's Nomination Committee for the 2018 Annual General Meeting
23/11/2017
PRESS RELEASE November 23, 2017 The Annual General Meeting on May 23, 2017, resolved that a Nomination Committee shall be appointed before coming election and remuneration. The Nomination Committee shall comprise three [...]
THIRD GLOBAL IRON DEFICIENCY DAY TO RAISE AWARENESS OF THE SYMPTOMS OF IRON DEFICIENCY
23/11/2017
Iron Deficiency Day takes place annually on 26 November to highlight the impact of iron deficiency, an under-recognised and underdiagnosed condition even in up-to-date healthcare systems. 1,2 This year's Iron Deficiency [...]
Probiodrug : Probiodrug AG to Publish its Third Quarter 2017 Business Update on 30 November 2017
23/11/2017
Probiodrug AG to Publish its Third Quarter 2017 Business Update on 30 November 2017 HALLE (SAALE), Germany, 23 November 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel [...]
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 15, 2017
22/11/2017
BETHESDA, Md., Nov. 22, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), adjourned again the voting for Proposals Three and Four from its Notice of Annual Meeting of Shareholders, dated [...]
Forward Pharma Announces Completion of Corporate Restructuring Plan
22/11/2017
COPENHAGEN, Denmark, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (“Forward Pharma”) today announced the completion of its previously announced corporate restructuring plan (the “Restructuring”) [...]
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
22/11/2017
BRIDGEWATER, N.J., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced the granting of [...]
RedHawk Announces First Quarter Results
22/11/2017
LAFAYETTE, La., Nov. 22, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today its results for the three-month period ended September 30, 2017 as it continues to [...]
Cannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UK
22/11/2017
VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ), (“Veritas” or the “Company”) announces that the scientists of its research arm, Cannevert [...]
TESARO Announces Participation in Two Investor Conferences
22/11/2017
WALTHAM, Mass., Nov. 22, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences [...]
Prothena to Participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference
22/11/2017
DUBLIN, Ireland, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in [...]
Adamas to Present at Two Upcoming Investor Conferences
22/11/2017
EMERYVILLE, Calif., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that company management is scheduled to present at two upcoming investor conferences: Richard A. King, [...]
GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor
22/11/2017
GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor Safety data, including adverse events and laboratory data, were reviewed by the [...]

Pages